High-Dose Omega-3 Supplements Found to Increase A-fib Risk

If you use these supplements, you should take aggressive lifestyle measures to lower the likelihood of developing this abnormal heart rhythm.

In the March issue, we introduced the landmark clinical trial of Epanova, a new prescription drug containing eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in four times the dose found in over-the-counter omega-3 supplements. In this trial, called STRENGTH, the stronger supplements were no better than placebo at protecting against cardiovascular death, nonfatal heart attack […]
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Heart Advisor

Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access